| Sandoz Pharmaceuticals AG - Omnitrope 15 mg, Injektionslösung |
| 61306 | | 03 | | Omnitrope 15 mg | | Injektionslösung | | H01AC01 | | Somatropin | | 01.09.2014 | | |
|
| Composition |
| somatropinum ADNr 15.0 mg corresp. 45 U.I., dinatrii phosphas heptahydricus, natrii dihydrogenophosphas dihydricus, poloxamerum 188, phenolum, natrii chloridum, acidum phosphoricum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 1.50 ml corresp. natrium 4.70 mg. |
| Packungsbestandteile |
| Solution injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Somatropinum Adnr | 15 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Somatropinum Adnr | 15 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acide Phosphorique | | | Disodium Phosphate Heptahydrate | | | Sodium Chlorure | | | Sodium Dihydrogenophosphate Dihydrate | | | Sodium Hydroxide | | | Phenol | | | Poloxamer | 188 |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 005 | pièce(s) | DDP | DDP | A | | Oui | | 006 | 5 pièce(s) | 2103.20 | 2303.75 | A | LS | Oui |
|
